Yohta Shimada

3.5k citations

51 papers · 875 indexed · h-index 19

Co-authors: Toya Ohashi Hiroyuki Ida Hiroshi Kobayashi Yoshikatsu Eto Takashi Higuchi Takahiro Fukuda Yohei Sato Hirotaka James Okano
Topics: Lysosomal Storage Disorders Research (34 papers)Trypanosoma species research and implications (10 papers)Neurogenetic and Muscular Disorders Research (7 papers)
Cited by: Physiology Genetics
Journals: Journal of Clinical Investigation Journal of Clinical Oncology Blood
Partner nations: Japan United States Taiwan

In The Last Decade

Yohta Shimada

49 papers receiving 859 citations

Peers

Countries citing papers authored by Yohta Shimada

Since Specialization

Citations

This map shows the geographic impact of Yohta Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohta Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohta Shimada more than expected).

Fields of papers citing papers by Yohta Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohta Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohta Shimada. The network helps show where Yohta Shimada may publish in the future.

Co-authorship network of co-authors of Yohta Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Yohta Shimada. A scholar is included among the top collaborators of Yohta Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohta Shimada. Yohta Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adeno-associated virus expressing a blood-brain barrier–penetrating enzyme improves GM1 gangliosidosis in a preclinical model 2025 ·Journal of Clinical Investigation ·S. Matsushima,Yohta Shimada,Masafumi Kinoshita,Takashi Nagashima,Shinichiro Okamoto,(unknown),(unknown),(unknown),Takashi Higuchi,Hiroyuki Hioki,Ayako M. Watabe,Hiroyuki Sonoda,Toya Ohashi,Hiroshi Kobayashi	0
2	Usefulness of antibody-drug conjugate as preconditioning for hematopoietic stem cell-targeted gene therapy in wild-type and Fabry disease mouse models 2024 ·Molecular Genetics and Metabolism ·(unknown),Yohta Shimada,Toya Ohashi,Hiroshi Kobayashi	1
3	Restoration of peripheral neuropathy in Fabry mice via intrathecal administration of an adeno-associated virus vector encoding mGLA cDNA 2024 ·Molecular Genetics and Metabolism ·Takashi Higuchi,Yohta Shimada,Yukari Takahashi,Fusao Kato,Toya Ohashi,Hiroshi Kobayashi	2
4	Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown),Toya Ohashi,Yohta Shimada,Takashi Higuchi,(unknown),Ayako M. Watabe,Fusao Kato,Hiroyuki Ida,Hiroshi Kobayashi	5
5	Screening for late‐onset Pompe disease in undiagnosed myopathies 2016 ·Neurology and Clinical Neuroscience ·(unknown),Kimiko Inoue,Saburo Sakoda,Tsuyoshi Matsumura,Takashi Hamazaki,Motomichi Kosuga,Torayuki Okuyama,Yohta Shimada,Toya Ohashi,Ichizo Nishino	0
6	Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II 2016 ·Molecular Genetics and Metabolism ·(unknown),(unknown),(unknown),Takashi Higuchi,Yohta Shimada,Hiroshi Kobayashi,Taku Sato,Toshiaki Ohteki,Makoto Otsu,Hiromitsu Nakauchi,Hiroyuki Ida,Toya Ohashi	14
7	TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle 2016 ·Molecular Therapy — Methods & Clinical Development ·Yohei Sato,Hiroshi Kobayashi,Takashi Higuchi,Yohta Shimada,Hiroyuki Ida,Toya Ohashi	35
8	Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient 2015 ·Molecular Therapy — Methods & Clinical Development ·Yohei Sato,Hiroshi Kobayashi,(unknown),Yohta Shimada,Takumi Era,Shigemi Kimura,Yoshikatsu Eto,Hiroyuki Ida,Toya Ohashi	37
9	Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II 2015 ·Human Gene Therapy ·(unknown),Yohta Shimada,(unknown),Takashi Higuchi,Takahiro Fukuda,Hiroshi Kobayashi,Yoshikatsu Eto,Hiroyuki Ida,Toya Ohashi	52
10	The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs 2014 ·Molecular Genetics and Metabolism ·Takashi Higuchi,(unknown),Makoto Otsu,Yohta Shimada,Hiroshi Kobayashi,(unknown),Koji Eto,Hiroyuki Ida,Toya Ohashi,Hiromitsu Nakauchi,Yoshikatsu Eto	22
11	Systemic accumulation of undigested lysosomal metabolites in an autopsy case of mucolipidosis type II; autophagic dysfunction in cardiomyocyte 2014 ·Molecular Genetics and Metabolism ·Yohei Sato,Hiroshi Kobayashi,Shun Sato,Yohta Shimada,Takahiro Fukuda,Yoshikatsu Eto,Toya Ohashi,Hiroyuki Ida	3
12	Adipose Tissue-Derived Mesenchymal Stem Cells in Long-Term Dialysis Patients Display Downregulation of PCAF Expression and Poor Angiogenesis Activation 2014 ·PLoS ONE ·Shuichiro Yamanaka,Shinya Yokote,Akifumi Yamada,(unknown),(unknown),Yohta Shimada,(unknown),Hirotaka James Okano,Takao Ohki,Takashi Yokoo	31
13	Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice 2013 ·Molecular Genetics and Metabolism ·(unknown),Yohta Shimada,Takashi Higuchi,Makoto Ohtsu,Hiromitsu Nakauchi,Hiroshi Kobayashi,Takahiro Fukuda,Hiroyuki Ida,Yoshikatsu Eto,Brett E. Crawford,Jillian R. Brown,Toya Ohashi	16
14	Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II 2012 ·Molecular Genetics and Metabolism ·Takashi Higuchi,Hiromi Shimizu,Takahiro Fukuda,(unknown),(unknown),Yohta Shimada,Hiroshi Kobayashi,Hiroyuki Ida,Toya Ohashi,Hideto Morimoto,Tohru Hirato,(unknown),Yoshikatsu Eto	42
15	Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease 2011 ·The Journal of Gene Medicine ·(unknown),Hiroshi Kobayashi,Yohta Shimada,Yoshikatsu Eto,Nobuyuki Ishige,Teruo Kitagawa,Makoto Otsu,Hiromitsu Nakauchi,Hiroyuki Ida,Toya Ohashi	8
16	Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation 2011 ·Biochemical and Biophysical Research Communications ·Yohta Shimada,(unknown),(unknown),Hiroshi Kobayashi,Takashi Higuchi,Yoshikatsu Eto,Hiroyuki Ida,Toya Ohashi	18
17	Pathology of the first autopsy case diagnosed as mucolipidosis type III α/β suggesting autophagic dysfunction 2010 ·Molecular Genetics and Metabolism ·Hiroshi Kobayashi,Junko Takahashi‐Fujigasaki,Takahiro Fukuda,(unknown),Yohta Shimada,Koichi Nomura,(unknown),Toya Ohashi,Yoshikatsu Eto,Takanobu Otomo,Norio Sakai,Hiroyuki Ida	16
18	Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: From our experience of 4 cases including an autopsy case 2010 ·Molecular Genetics and Metabolism ·Hiroshi Kobayashi,Yohta Shimada,Masahiro Ikegami,Toshinao Kawai,Ken Sakurai,Takashi Urashima,(unknown),Masako Fujiwara,(unknown),Toya Ohashi,Yoshikatsu Eto,Keiko Ishigaki,Makiko Ōsawa,Sandra Obikawa Kyosen,Hiroyuki Ida	42
19	Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells 2006 ·The International Journal of Biochemistry & Cell Biology ·Jiro Minami,Koji Takada,Katsuhiko Aoki,Yohta Shimada,Yutaka Okawa,Noriko Usui,Kiyoshi Ohkawa	9
20	Quality Evaluation on Paeoniae Radix. I. Quantitative Analysis of Monoterpene Glycosides Constituents of Paeoniae Radix by Means of High Performance Liquid Chromatography. Comparative Characterization of the External Figures, Processing Method and the Cultivated Areas 1996 ·YAKUGAKU ZASSHI ·(unknown),Taeko Fukuda,(unknown),Yohta Shimada,(unknown),(unknown),(unknown)	19

About Yohta Shimada

Yohta Shimada is a scholar working on Physiology, Physiology and Genetics, having authored 51 papers that have together received 875 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (34 papers), Trypanosoma species research and implications (10 papers) and Neurogenetic and Muscular Disorders Research (7 papers). The work is most often cited by research in Physiology (462 citations), Physiology (66 citations) and Genetics (111 citations). Yohta Shimada has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Toya Ohashi, Hiroyuki Ida, Hiroshi Kobayashi, Yoshikatsu Eto, Takashi Higuchi, Takahiro Fukuda, Yohei Sato, Takashi Higuchi, Hirotaka James Okano and Tadashi Uwagawa. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact